Ascendis Pharma A (ASND) Net Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) Net Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 680.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 35,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,025.00 |
| Dec 31, 2025 | 423.00 |
| Sep 30, 2025 | 14,224.00 |
| Jun 30, 2025 | -32,932.00 |
| Mar 31, 2025 | -23,045.00 |
| Dec 31, 2024 | 1,678.00 |
| Sep 30, 2024 | 16,620.00 |
| Jun 30, 2024 | 4,548.00 |
| Mar 31, 2024 | 46,920.00 |
| Dec 31, 2023 | 87,676.00 |
| Sep 30, 2023 | 78,171.00 |
| Jun 30, 2023 | 159,077.00 |
| Mar 31, 2023 | 150,544.00 |
| Dec 31, 2022 | -78,282.00 |
| Sep 30, 2022 | -833,849.00 |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | 657,917.00 |
| Dec 31, 2021 | 88,838.00 |
| Sep 30, 2021 | 1.16 Mn |
| Jun 30, 2021 | 652,704.00 |